Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan and nebivolol for intradialytic hypertension in hemodialysis patients
ISRCTN13587185Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki School of Medicine
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of irbesartan and nebivolol in Intradialytic hypertension (IDH) (2 arms), sponsored by Aristotle University of Thessaloniki School of Medicine. Primary endpoints: Ambulatory brachial blood pressure, Ambulatory central blood pressure and 1 more. Started Jun 2016; status: completed.
02
Drugs
irbesartannebivolol
03
Conditions
Intradialytic hypertension (IDH)
Beyond the preview
Go deeper on ISRCTN13587185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13587185.